- Global Pharma News & Resources

Transcatheter Heart Valve Replacement (TAVR) Market is projected to grow at a CAGR of 14.8% between 2023 and 2033

The global Transcatheter Heart Valve Replacement (TAVR) Market is valued at US$ 5.7 billion in 2022, and it is expected to grow at a 14.8% CAGR over the forecasted years. According to a recent Future Market Insights study, balloon-expandable transcatheter aortic valves will command a market share of approximately 52.5% in 2022.

The report focuses on providing key insights into various market features such as demand, product developments, revenue generation, and sales in the Transcatheter Heart Valve Replacement (TAVI) market. The study provides a detailed analysis of market dynamics such as drivers, restraints, opportunities, and challenges, as well as their impact on the market.

The market is expected to grow as a result of ongoing clinical research in TAVR innovations, providing a huge opportunity for market players to enter the market.

Cardiovascular experts who treat some of the most complex heart conditions using cutting-edge technology and groundbreaking research, such as transcatheter aortic valve replacement (TAVR), lead several comprehensive programs. TAVR is a new, rapidly evolving therapy that provides patients with the best TAVR technology available.

Request a Sample of this Report:

Advent of Telehealth and Virtual Care to Create Tailwind for the Transcatheter Heart Valve Replacement (TAVI) Market Growth

Digitization is making deeper inroads across diverse industries, such as healthcare, owing to the increasing penetration of the internet and smartphones across the world.

During the COVID-19 outbreak, healthcare practitioners and patients realized the importance of digitization and encouraged them to adopt virtual methods of patient examination and consultation to counter the regulations concerning social distancing. This gave rise to a new medical domain, Telehealth.

Since the outbreak, telehealth have gained immense popularity, especially among the geriatric population, owing to the convenience associated with it. Hence, increasing adoption of telehealth across radiology, behavioral health, cardiology, and online consultation is expected to create lucrative opportunities for growth in the Transcatheter Heart Valve Replacement (TAVI) market.

Key Transcatheter Heart Valve Replacement (TAVI) Market Takeaways and Projections

  • The U.S. is estimated to continue dominating the North America market, projecting fastest growth in the region through 2031.
  • Germany Transcatheter Heart Valve Replacement (TAVI) market is forecast to register robust growth in Europe, accounting for a significant share in the region between 2021 and 2031.
  • China is expected to account for the maximum revenue share in the East Asia market, exhibiting the fastest sales growth during the assessment period.
  • India is forecast to emerge as a highly remunerative market in South Asia, contributing for the largest sales in the region over the coming 10-years.

Inquire Before Buying Research Report:

Report Benefits & Key Questions Answered

  • Transcatheter Heart Valve Replacement (TAVI) Historical Market Outlook: Future Market Insight’s analysis examines vital dynamics, such as drivers, opportunities, and challenges in the Transcatheter Heart Valve Replacement (TAVI) market. It also studies the impact of these dynamics on the market for the previous assessment period 2016-2020 to forecast the scope of market growth over the coming forecast period 2021-2031.
  • Transcatheter Heart Valve Replacement (TAVI) Demand-Supply Assessment: The latest study published by FMI offers in-depth insights into governing factors facilitating the demand outlook of the Transcatheter Heart Valve Replacement (TAVI) market. As per the survey, Transcatheter Heart Valve Replacement (TAVI) sales will project steady growth over the forecast period.
  • Transcatheter Heart Valve Replacement (TAVI) Market Structure Analysis: The report provides detailed information about market the concentration of key players and tier analysis in the Transcatheter Heart Valve Replacement (TAVI) market. It also categories market players as per Tier 1, Tier 2, and Tier 3 in terms of their percentage share and product portfolio.
  • Transcatheter Heart Valve Replacement (TAVI) Category & Segment Level Analysis: FMI’s category & segment level analysis provides insights into key factors affecting the market growth across various segments in terms of (segment 1), (segment 2), and (segment 3). It also uncovers critical opportunities across each segment to assist key players to capitalize on the,
  • Transcatheter Heart Valve Replacement (TAVI) Market Trend Analysis: FMI’s market trend analysis provide compelling insights into current and upcoming trends in the healthcare industries. It also assists the industry players to identify potential trends to formulate a strategy to take advantage of these existing trends.

Competitive Landscape Analysis

The latest study conducted by FMI provides in-depth insights into the global Transcatheter Heart Valve Replacement (TAVI) market to assist management level decision-makers in constructing a strategy to capitalize on the critical trends & opportunities. It also discloses competitive trends and profiles a list of leading players operating in the global Transcatheter Heart Valve Replacement (TAVI) market.

Use promo code ->> FMITODAY to get a flat 20% discount

Key Companies Profiled:

  • Abbott
  • Edwards Lifesciences Corporation
  • Medtronic
  • Boston Scientific Corporation
  • JenaValve Technology, Inc
  • Meril Life Sciences
  • Sahajanand Medical Technologies Limited
  • MicroPort Scientific Corporation
  • Venus Medtech (Hangzhou) Inc.
  • Suzhou Jiecheng Medical Technology Co. Ltd.
  • Peijia Medical Limited.
  • Blue Sail Medical Co., Ltd.

Key Market Segments Covered in the Transcatheter Heart Valve Replacement Industry Research


  • Self – Expandable Transcatheter Aortic Valves
  • Balloon-Expandable Transcatheter Aortic Valves
  • Mechanically Expanded Transcatheter Aortic Valves


  • Severe Aortic Valve Stenosis
  • Valve-in-Valve Procedures (Failed Bioprosthesis)
  • Aortic Regurgitation

End User:

  • Hospitals
  • Independent Cardiac Catheterization Labs
  • Ambulatory Surgical Centres

Have a Look at Related Research Reports in the Healthcare Domain:

About Future Market Insights (FMI) 

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.


Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries:
Browse All Reports:

Editor Details

Last Updated: 16-Mar-2023